Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures

Delivering Commitment to Find New Treatment Options for Patients Suffering from Sacral Insufficiency Fractures DUBLIN - June 20, 2018- Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of ... Devices, Interventional, Radiology, Orthopaedic, FDA Medtronic, Kyphon, Kyphon HV-R, Bone Cement, Sacral Insufficiency

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2044009

Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

More News: Food and Drug Administration (FDA) | Orthopaedics | Pharmaceuticals | Radiology